In The News in Bellevue and Seattle

We hope you will find these articles and press releases informative and interesting as you move along your journey with cosmetic surgery. Check back often for breaking news. Please direct media inquiries to [email protected].

Juvéderm® VOLUX™ XC, Gains FDA-Approval for Jawline Improvement

by Dr. Egrari

JUVÉDERM® VOLUX™ XC is the first and only hyaluronic acid (HA) filler to receive U.S. FDA approval for improving jawline definition. For adults over the age of 21 with moderate to severe jawline definition loss, this cutting-edge injectable represents the most significant leap in innovation for the JUVÉDERM® HA portfolio…

Read more

Juvéderm® Volbella® XC, Is Now The First And Only Dermal Filler To Receive FDA Approval For Use Under The Eyes

by Dr. Egrari

Volbella, one of the dermal fillers in the most popular dermal filler family, Juvederm, has now become FDA-approved for filling hollows and circles under the eyes. This is the latest news from Allergan Aesthetics, an AbbVie company. Clinical trials have shown that 90% of subjects were satisfied after one year following their treatment with Volbella for under-eye hollows…

Read more

Allergan Receives FDA Clearance For The Coolsculpting ® Treatment To Improve Appearance Of Lax Tissue In The Double Chin

by Dr. Egrari

Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment is the first and only non-surgical fat reduction technology to be FDA-cleared for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. CoolSculpting for the double chin is already clinically proven to reduce fat up to 20 percent in the treated…

Read more

Mentor Receives FDA Approval For Mentor ® Memoryshape ™ Breast Implants

by Dr. Egrari

Newly Available Teardrop-Shaped Breast Implants Provide Natural Silhouette and Youthful Feel SANTA BARBARA, Calif., June 14, 2013 /PRNewswire/ — Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, today announced the U.S. Food and Drug Administration (FDA) has approved MENTOR® MemoryShape™ Breast Implants, providing new options for women looking for a more natural shape…

Read more

Bellevue Physician Promoting Living Skin Donation

by Dr. Egrari

Bellevue, WA — Obesity has become a national epidemic. Each year, across many different age groups, the number of overweight Americans has been on the rise. One of the most effective means of battling morbid obesity is Bariatric Surgery, which — in appropriate candidates — can dramatically reduce massive weight. However, along with such weight…

Read more

Silicone Breast Implants Approved With Conditions

by Dr. Egrari

Plastic Surgery Societies Applaud FDA Panel Recommendation That Mentor’s Silicone Breast Implants Be Approved With Conditions Gaithersburg, MD — The U.S. Food and Drug Administration advisory panel’s 7-2 vote today to recommend to the FDA that Mentor’s silicone breast implants be approved with conditions is applauded by the American Society of Plastic Surgeons (ASPS) and…

Read more

Unlicensed Raw Botulinum Toxin Source Of Patients Illness In Florida

by Dr. Egrari

ALLERGAN’S BOTOX® (BOTULINUM TOXIN TYPE A) NOT THE CAUSE OF BOTULISM IN FLORIDA PATIENTS — FDA Affadavit Identifies Unlicensed Raw Botulinum Toxin as Source of Patient’s Illnesses Irvine, CA — Allergan, Inc. (NYSE: AGN) announced today that a U.S. Food and Drug Administration (FDA) affidavit filed in the U.S. Federal District Court reveals that BOTOX®…

Read more

Leo & Jessica's Journey: One Year Later, 352 Pounds Lighter

by Dr. Egrari

Link to Seattle Times article, “Leo & Jessica’s Journey: One Year Later, 352 Pounds Lighter.” Dr. Egrari helped this couple with their post-weightloss body contouring.

Read more

Sepehr Egrari Md Facs Offers Revolutionary New Wrinkle Treatment - Radiesse®

by Dr. Egrari

Revolutionary New Wrinkle Treatment — Radiesse® Healthy young skin contains collagen that gives it volume, flexibility and strength. As part of the aging process, your own natural collagen breaks down, diminishing facial volume. This loss of elasticity and volume results in the wrinkles, facial lines and skin laxity that rob your skin of its youthful…

Read more

FDA Advisory Panel Recommends Opening Market For Silicone Breast Implants

by Dr. Egrari

F.D.A. Panel Backs Silicone Breast Implants Gaithersburg, MD — After 11 years off the market, an advisory panel to the Food and Drug Administration has voted to recommend that silicone breast implants be allowed to be used in breast surgery. The FDA typically follows the recommendations of the advisory panel and expects to make a…

Read more

Breast Cancer Awareness Facts From The American Society Of Plastic Surgeons

by Dr. Egrari

National Breast Cancer Awareness Month Last year, more than 203,000 women were diagnosed with breast cancer. This year, an estimated 211,000 more will receive the same diagnosis. Because breast cancer is 90 percent curable when caught early, women need to know how important it is to perform regular self breast-exams. Losing a breast is both…

Read more

Statement From American Society Of Aesthetic Plastic Surgeons Regarding Fictional Portrayal Of Plastic Surgery In Tv Show "Nip/tuck"

by Dr. Egrari

Fictional Portrayal of Plastic Surgery Does More Than Miss the Mark New York, NY — “Nip/Tuck,” a fictional television series that focuses on the personal and professional lives of two plastic surgeons, does not even remotely portray the “real life” world of plastic surgery and does a disservice to millions of patients who benefit from…

Read more

Bellevue Plastic Surgeons To Hold BOTOX® Event Benefiting Overlake Hispital Children's Service & Oncology Clinic

by Dr. Egrari

Bellevue Plastic Surgeons to Hold BOTOX® Event Benefiting Overlake Hospital Children’s Service & Oncology Clinic Bellevue, WA — Dr. Aysel Sanderson and Dr. Sepehr Egrari announced today that they will be conducting a two-day BOTOX® event December 6th & 7th in their offices, the proceeds of which will benefit children’s services and a state-of-the-art oncology…

Read more

JUVÉDERM VOLUMA™ XC

What is JUVÉDERM VOLUMA™ XC injectable gel?

JUVÉDERM VOLUMA™ XC injectable gel is the first and only filler FDA-approved to instantly add volume to the cheek area. It gives you a subtle lift, helping to restore contour and a more youthful profile, for up to 2 years, in patients over the age of 21. It’s different than JUVÉDERM® XC and works on a different area of the face. JUVÉDERM® XC smoothes out moderate to severe wrinkles and folds around the nose and mouth, like parentheses. JUVÉDERM VOLUMA™ XC, however, adds volume to the cheek area.

The Press Room - Egrari Plastic Surgery Center

What else should you know about JUVÉDERM VOLUMA™ XC?

  • First and only Hyaluronic Acid (HA) filler FDA-approved to instantly add volume to the cheek area, resulting in a subtle lift
  • Clinically proven to last up to 2 years with optimal treatment
  • JUVÉDERM VOLUMA™ XC is from the makers of the #1 family of fillers
  • After 24 hours, you should be able to resume your normal activities
  • Side effects are moderate and generally last 2 to 4 weeks. Common side effects include temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching.

COVID RESOURCES

WE ARE OPEN!

We have been fully operational since May of 2020. With patience and with care, we all are returning to normalcy. Our office continues to use safety protocols, and we are eager to see you.

ALTHOUGH OPEN, WE ARE HERE FOR YOU VIRTUALLY AS WELL

For patients who desire a virtual consultation, this option is available.
Our virtual web consultations can be done right in the comfort of your own home. All you need is a secure Internet connection and a computer, tablet, or smartphone.
If you would like to have a VIRTUAL CONSULTATION or have any questions, please give us a call at (425) 827-7878 or contact us via our website to set up your virtual consultation today.

PRACTICE POLICY UPDATE FOR CORONAVIRUS (Covid-19):

Updated May 2022
We have been fully operational since May of 2020. This includes skincare and our non-invasive center (ENIC).
We know that so much of this pandemic caused an inconvenience for you, but we are delighted to see a return to normalcy. 
We will continue to be vigilant in our approach to Covid 19. For over two decades, we have considered safety as our most important prerogative — and there has never been a more important time to put that to use.
Here are some things we’re doing to ensure you are protected and that we maintain this facility as a Non-Covid Care (NCC) zone:

Patient Flow and Clinical Office Space

We now have a well-tested protocol of texting patients for control of flow for consultations.
We are assigning everyone to hourly wipe-downs of high-use areas with approved sanitizing wipes.
We are asking that no one wait in the waiting area.
We are coming up with protocols for room wipe-downs after each patient visit.
Every staff member will always wear a mask while in the office.
Every staff member will sanitize or wash hands after every interaction.
Implementation of virtual pre-ops, nursing visits, and questions.


Operating Room Experience

Similar precautions and questionnaires will be provided to establish Covid-19 Clear Status.
All staff will always wear a mask. All staff will always wear gloves.
Hand washing will be done for any patient interaction.
Specific wipe-down of our operating room, recovery, and pre-op areas will be performed.
We will minimize accompanying caretakers to only one. Those caretakers will be treated just like the patients.
Anesthesia Experience
Every anesthesia staff will wear goggles and other protective equipment during intubation.
Our anesthesiologists have been fully trained and are implementing all precautions for prevention of Covid-19 spread.
All circuits will be changed between each patient.
Full wipe-down of surfaces and floors will be performed.
We will implement a time-out protocol to confirm the Covid-19 Clear Status of every patient.


As you can see, we are taking this very seriously. We fully understand that this will cause some inconvenience in the short term, but realize that it is for the best.
Although Covid-19 has been a serious issue, we are seeing a resumption of normalcy. We continue to monitor this situation on a real-time basis, and we will not sit back until we know that we have done everything possible to avoid unnecessary exposure.
When you see us in action, you’ll realize that you have put your trust in the right practice.
Here are some links that might be useful:
State of Washington Department of Health
Centers for Disease Control and Prevention (CDC)
World Health Organization (WHO)
Please do not hesitate to contact us. We are always here to answer your questions!
Call us at (425) 827-7878
Email us at [email protected]
VIRTUAL CONSULTATION

Contact us media

Terms & Conditions Privacy Policy Sitemap

© Egrari. All Rights Reserved.

Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (425) 827-7878.
Contact Us